Karen Tumaneng
Regeneron (United States)(US)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Wnt/β-catenin signaling in development and cancer, PI3K/AKT/mTOR signaling in cancer, Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis
Most-Cited Works
- → Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling(2012)1,629 cited
- → A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCFβ-TRCP(2010)1,422 cited
- → The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal(2011)1,210 cited
- → YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29(2012)453 cited
- → Organ Size Control by Hippo and TOR Pathways(2012)187 cited
- → Ras drives malignancy through stem cell crosstalk with the microenvironment(2022)88 cited
- → YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR‐29(2013)13 cited
- Elucidation of the mechanisms of the Hippo-YAP pathway in organ size control and cancer(2013)
- → CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A Prospective, Non-Interventional Study of the Safety and Effectiveness of Cemiplimab in Immunocompromised/Immunosuppressed Patients With Advanced Cutaneous Squamous Cell Carcinoma at 2 Years’ Follow-Up(2026)